Xufang Zhang Selected Research

Pain (Aches)

1/2017

Structural characterization of nonactive site, TrkA-selective kinase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xufang Zhang Research Topics

Disease

3	Periodontitis 12/2018 - 01/2014
2	Inflammation (Inflammations) 08/2014 - 01/2014
1	Renal Insufficiency (Renal Failure) 06/2023
1	Acute Kidney Injury (Acute Renal Failure) 06/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Chronic Pain 01/2017
1	Pain (Aches) 01/2017
1	Hypertrophy 01/2016
1	Osteoarthritis 01/2016
1	Necrosis 01/2016
1	Hypertrophic Cicatrix (Hypertrophic Scar) 10/2015

Drug/Important Bio-Agent (IBA)

2	NF-kappa B (NF-kB)IBA 01/2017 - 01/2014
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Cystatin CIBA 06/2023
1	SiliconIBA 06/2023
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2018
1	AntibodiesIBA 01/2017
1	LigandsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	TropomyosinIBA 01/2017
1	Nerve Growth Factor (NGF)IBA 01/2017
1	CateninsIBA 01/2017
1	parthenolideIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	shikoninIBA 10/2015
1	CollagenIBA 10/2015
1	HMGB1 Protein (HMG1)IBA 08/2014

Therapy/Procedure

1	Therapeutics 01/2017